Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
Portfolio Pulse from
Amphastar Pharmaceuticals (AMPH) reported Q4 earnings of $0.92 per share, missing the Zacks Consensus Estimate of $0.96. This is a slight improvement from $0.88 per share a year ago.
February 28, 2025 | 12:30 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amphastar Pharmaceuticals reported Q4 earnings of $0.92 per share, missing the Zacks Consensus Estimate of $0.96. This slight miss may impact short-term stock performance.
The earnings miss against the consensus estimate is likely to have a negative short-term impact on Amphastar's stock price as it indicates the company did not meet market expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100